Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Provan

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|April 15, 2026
MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopeniaZhenyu Liu, Johan Rebetz, Lamya Garabet, et al.
Blood Vessels, Thrombosis & Hemostasis|May 20, 2026
Sustained response after rilzabrutinib discontinuation in multirefractory immune thrombocytopeniaTomás José González-López, Fernando Orza, Amalia Cuesta-García, et al.
British Journal of Haematology|July 15, 2021
Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI)Nichola Cooper, Adam Cuker, Nicola Bonner, et al.
Acta Haematologica|March 31, 2021
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi PanelNichola Cooper, Quentin A Hill, John Grainger, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2011
Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adultsAmeet Sarpatwari, James B Bussel, Momin Ahmed, et al.
European Journal of Haematology|February 14, 2019
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP RegistryIndraraj Umesh Doobaree, Adrian Newland, Vickie McDonald, et al.
Frontiers in Cardiovascular Medicine|January 1, 2024
Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittentlyMohamed A Yassin, Mona Al-Rasheed, Murtadha Al-Khaboori, et al.
British Journal of Haematology|June 5, 2007
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITPLemke K Page, Bethan Psaila, Drew Provan, et al.
Haematologica|March 13, 2016
A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopeniaShaun M Flint, Adele Gibson, Geoff Lucas, et al.
Frontiers in Medicine|April 26, 2024
A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndromeAlaa Rahhal, Drew Provan, Waleed Ghanima, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|April 15, 2026
MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopeniaZhenyu Liu, Johan Rebetz, Lamya Garabet, et al.
Blood Vessels, Thrombosis & Hemostasis|May 20, 2026
Sustained response after rilzabrutinib discontinuation in multirefractory immune thrombocytopeniaTomás José González-López, Fernando Orza, Amalia Cuesta-García, et al.
British Journal of Haematology|July 15, 2021
Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI)Nichola Cooper, Adam Cuker, Nicola Bonner, et al.
Acta Haematologica|March 31, 2021
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi PanelNichola Cooper, Quentin A Hill, John Grainger, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2011
Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adultsAmeet Sarpatwari, James B Bussel, Momin Ahmed, et al.
European Journal of Haematology|February 14, 2019
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP RegistryIndraraj Umesh Doobaree, Adrian Newland, Vickie McDonald, et al.
Frontiers in Cardiovascular Medicine|January 1, 2024
Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittentlyMohamed A Yassin, Mona Al-Rasheed, Murtadha Al-Khaboori, et al.
British Journal of Haematology|June 5, 2007
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITPLemke K Page, Bethan Psaila, Drew Provan, et al.
Haematologica|March 13, 2016
A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopeniaShaun M Flint, Adele Gibson, Geoff Lucas, et al.
Frontiers in Medicine|April 26, 2024
A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndromeAlaa Rahhal, Drew Provan, Waleed Ghanima, et al.
Pageof 9